News: We’re delighted to announce that Envision Pharma Group, a global technology-enabled strategic solutions provider for life science, has become a member of the Proud Science Alliance. Learn more about Envision: https://bit.ly/4bCq0Kv #ProudScienceAlliance
Proud Science Alliance’s Post
More Relevant Posts
-
Deloitte is making five bold 2024 life sciences M&A predictions, which include another strong year for pharma M&A and a positive turn for the MedTech market. Find out what else we expect this year.
To view or add a comment, sign in
-
Today, our Chief Executive Dr June Raine spoke at the Financial Times 2023 Global Pharma and Biotech Summit about enabling innovation through effective regulation #FTpharma For the MHRA, this means regulation driving innovation across the whole product lifecycle – from the lab through to the delivery of life-saving medical products into the hands of those who need them. Where there is a potential to improve healthcare for patients, we make it a priority. For more information, read our corporate plan: https://bit.ly/3Z6k1Iu
To view or add a comment, sign in
-
-
𝐇𝐚𝐩𝐩𝐲 𝐌𝐨𝐧𝐝𝐚𝐲, 𝐞𝐯𝐞𝐫𝐲𝐨𝐧𝐞! 🎉 As we start the week, I’m excited by the incredible events happening today in the biotech and pharmaceutical industries. The FT Live US Pharma and Biotech Summit 2024 is kicking off in New York, bringing together leaders to discuss the latest trends and innovations in life sciences. Additionally, the Sanford/PPALS PACT course is being held in Sioux Falls, focusing on patient advocacy within the biotech and pharmaceutical industries. Moreover, Siemens Realize LIVE 2024 is happening this week, where industry experts will converge to discuss digital transformation and innovation. This event is a fantastic opportunity to explore the latest advancements in digital industries and how they can be applied to enhance operational efficiency. At Azteria Technology, we are dedicated to driving digital transformation and enhancing operational efficiency. Whether it's through our advanced innovation deploying Siemens Digital Industries Software Opcenter Manufacturing Execution Systems (MES) or process optimization solutions, we aim to support your organization in staying ahead of industry changes. How is your organization leveraging digital transformation in the life sciences sector? Are you attending any industry events this week? Let’s discuss in the comments! #DigitalTransformation #LifeSciences #Biotech #Pharma #AzteriaTech #IndustryEvents #SiemensRealizeLIVE
To view or add a comment, sign in
-
𝐏𝐫𝐢𝐧𝐜𝐢𝐩𝐚𝐥 𝐂𝐨𝐧𝐬𝐮𝐥𝐭𝐚𝐧𝐭 𝐚𝐧𝐝 𝐅𝐨𝐮𝐧𝐝𝐞𝐫 𝐚𝐭 𝐀𝐳𝐭𝐞𝐫𝐢𝐚 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 | Pioneering Digital Manufacturing & Innovation in Life Sciences
𝐄𝐱𝐜𝐢𝐭𝐢𝐧𝐠 𝐭𝐢𝐦𝐞𝐬 𝐚𝐭 Azteria Technology! 🌟 We’ve just shared an insightful post on our company page highlighting some key events in the biotech and pharmaceutical industries, including the FT Live US Pharma and Biotech Summit, the Sanford/PPALS PACT course, and Siemens Realize LIVE 2024. These events are pivotal for discussing the latest trends, innovations, and advancements in our field. At Azteria, we’re dedicated to driving digital transformation and operational efficiency. I’d love to connect and explore how these advancements can benefit your organization. Check out the full post on our company page here. Let’s discuss how we can leverage these opportunities together! #DigitalTransformation #LifeSciences #Biotech #Pharma #AzteriaTech #IndustryEvents #SiemensRealizeLIVE
𝐇𝐚𝐩𝐩𝐲 𝐌𝐨𝐧𝐝𝐚𝐲, 𝐞𝐯𝐞𝐫𝐲𝐨𝐧𝐞! 🎉 As we start the week, I’m excited by the incredible events happening today in the biotech and pharmaceutical industries. The FT Live US Pharma and Biotech Summit 2024 is kicking off in New York, bringing together leaders to discuss the latest trends and innovations in life sciences. Additionally, the Sanford/PPALS PACT course is being held in Sioux Falls, focusing on patient advocacy within the biotech and pharmaceutical industries. Moreover, Siemens Realize LIVE 2024 is happening this week, where industry experts will converge to discuss digital transformation and innovation. This event is a fantastic opportunity to explore the latest advancements in digital industries and how they can be applied to enhance operational efficiency. At Azteria Technology, we are dedicated to driving digital transformation and enhancing operational efficiency. Whether it's through our advanced innovation deploying Siemens Digital Industries Software Opcenter Manufacturing Execution Systems (MES) or process optimization solutions, we aim to support your organization in staying ahead of industry changes. How is your organization leveraging digital transformation in the life sciences sector? Are you attending any industry events this week? Let’s discuss in the comments! #DigitalTransformation #LifeSciences #Biotech #Pharma #AzteriaTech #IndustryEvents #SiemensRealizeLIVE
To view or add a comment, sign in
-
Top M&A deals of 2023 Unlike in previous years, there were no mega deals with over $50bn in value among the top deals in the U.S. This is consistent with the lower level of M&A activity overall. From the industry perspective, biotech, life sciences, pharma and healthtech were the most active industries for large deals in 2023 while software and technology dominated large deals in 2022.
To view or add a comment, sign in
-
-
Austria is leading the way in Europe’s life sciences landscape, boasting a significant number of biotech, pharmaceutical, and medical technology enterprises 🧬 Acknowledging Austria’s pivotal role, we hosted our very own BOLD Salon to gather insights from both international and local BOLD Minds who are actively shaping the economy of tomorrow. During our BOLD Salon, we curated three engaging sessions, where BOLD Minds leading diverse fields exchanged ideas on healthcare and innovations within the medical sector 👩⚕️ Listen to BOLD Mind, Julie Rosser, CEO at Pregenerate Inc., who co-hosted a stimulating discussion on the potential of #AI to enhance and disrupt healthcare and medicine when integrated with other technologies. How do you envision technology improving healthcare in the future? Share your thoughts below! #BOLDCommunity #BOLDSalon #healthcare #innovations #medicalcare #medicine
To view or add a comment, sign in
-
If 2022 brought a steep decline for biopharma funding, 2023 was the year of the rebound with the level of activity exceeding 2019 levels. The Global Trends in R&D 2024 report shared the following points about 2023’s increase in funding activity: ✔️In 2023 alone, follow-on funding represented about 38% of biopharma funding, for which 91% was comprised of companies headquartered in the U.S. ✔️High profile and high value deals indicate robust interest from investors and innovators in the next generation of therapies. ✔️The shifts in deal activity reflect changes in the types of companies being invested in, their therapeutic focus, and where they are located. Explore the forces driving innovation in R&D by downloading the report: https://bit.ly/4a3B6qJ. #RandD #GlobalHealth
To view or add a comment, sign in
-
-
Interested in learning about pharma's R&D decision making for investment? Register today for the ELabNYC masterclass, https://lu.ma/dto1urzy Use our discount code for your ticket! Our discount code 1KEQL1 gives you 20% off. This code is valid through February 1, 2024. Topics include: Assessment of competition and risk Importance of a Target Product Profile (TPP) Role of market assessment Meaningful milestones in an R&D program Reducing clinical risk in the preclinical program GO/NO GO decision points When external R&D becomes important
To view or add a comment, sign in
-
-
More evidence that the IRA is not likely to have any negative impact on innovation.
If 2022 brought a steep decline for biopharma funding, 2023 was the year of the rebound with the level of activity exceeding 2019 levels. The Global Trends in R&D 2024 report shared the following points about 2023’s increase in funding activity: ✔️In 2023 alone, follow-on funding represented about 38% of biopharma funding, for which 91% was comprised of companies headquartered in the U.S. ✔️High profile and high value deals indicate robust interest from investors and innovators in the next generation of therapies. ✔️The shifts in deal activity reflect changes in the types of companies being invested in, their therapeutic focus, and where they are located. Explore the forces driving innovation in R&D by downloading the report: https://bit.ly/4a3B6qJ. #RandD #GlobalHealth
To view or add a comment, sign in
-
-
🚀 What pharma wants: The industry's dealmakers look ahead at 2024 🚀 Were you able to attend today's #jpm2024, if not, check out these insights. As we venture into 2024, the pharmaceutical industry is at a pivotal junction, blending scientific discovery with strategic foresight. This year, it's not just about what we're developing, but how we're innovating through collaborations and partnerships. We must dive deep into the science (not finances), prioritizing patient-centric solutions, and aligning our visions to drive transformative outcomes. Let's connect, collaborate, and create a future where healthcare innovation isn't just a goal, but a reality. Remember, most deals start as collaborations. Resiliency is required and you have to play the long game. An incredible presentation and insight into this was presented at JPM Healthcare today by: Glenn Hunzinger Rachna Khosla James Sabry Devang Bhuva John Carroll #InnovateHealthcare #FutureOfHealthcare #innovation #PharmaPartnerships
To view or add a comment, sign in